Archive
Every update, milestone, and publication from Seek Labs.
Seek Labs Appoints Kim Wirthlin as Chief Strategy Officer March 19, 2025 SALT LAKE CITY, UT, March 19, 2024 (BusinessWire)- Seek Labs, a healthcare innovations company developing diagnostic and therapeutic solutions that have the potential to revolutionize the detection and treatment of diseases, is pleased to announce the appointment of Kim Wirthlin as Chief Strategy…
Seek Labs Recognized in the Global Seafood Advocate for Advancing Aquaculture Disease Detection March 11, 2025 Seek Labs is proud to be featured in the Global Seafood Advocate for our work in advancing pondside molecular diagnostics. Our Seekit™ WSSV Field Kit enables shrimp farmers to detect White spot syndrome virus (WSSV) on-site and in minutes,…
Craig Mosman, Chief Business Development Officer, to Step Down from Seek Labs and Move into Advisory Role January 10, 2025 Seek Labs announced today that Craig Mosman, Chief Business Development Officer, will be stepping down from his role, effective January 6, 2025. While stepping back from his current role, Mosman will continue to support the…
Seek Labs Welcomes Brooke Clark as Vice President of People January 8, 2025 Seek Labs is excited to announce the appointment of Brooke Clark as Vice President of People, effective December 30, 2024. With over two decades of expertise in talent acquisition, coaching, mentorship, and people strategy, Clark brings a deep passion for fostering team…
Seek Labs Publishes 2024 Corporate Social Responsibility Report October 10, 2024 We are excited to announce the publication of Seek Labs’ first Corporate Social Responsibility Report, which showcases our commitment to ethical practices, sustainable innovation, and community engagement. This report highlights our efforts to make a positive impact across environmental, social, and governance (ESG) structures–from…
Seek Labs has completed two external validation studies for its SeekIt WSSV Field Kit in collaboration with Florida Atlantic University’s Aquatic Animal Health Lab (AAHL) and ShrimpVet Laboratory.
Seek Labs Announces Returnship Program September 25, 2024 Seek Labs is excited to announce the launch of its Returnship Program in partnership with BioHive. Seek Labs’ Returnship Program aims to support and provide opportunities for individuals who have taken an extended absence from their career. Seek Labs hopes to reduce barriers to employment by actively…
Seek Labs Joins Global African Swine Fever Research Alliance (GARA) September 16, 2024 Seek Labs is excited to announce its participation in the Global African Swine Fever Research Alliance (GARA), a global collaborative effort dedicated to fighting African Swine Fever (ASF). With its innovative CRISPR-based therapeutic technology platform, Seek Labs is set to play a…
Seek Labs at Next Generation Dx Summit in Washington, D.C. August 22, 2024 The 2024 Next Generation Dx Summit, held from August 19-21 in Washington, D.C., was a gathering of forward-thinking minds in point-of-care diagnostic technologies, and Seek Labs was proud to be a key participant and sponsor. Jared Bauer, CEO, delivered a highly anticipated…
Seek Labs to Sponsor and Exhibit at the 2024 Next Generation Dx Summit in Washington, D.C. August 12, 2024 SALT LAKE CITY, UT, August 12, 2024 (Business Wire) – Seek Labs, a healthcare innovations company developing next-generation point-of-care molecular diagnostic systems and a novel CRISPR-based pharmaceutical technology platform, is excited to announce its sponsorship and…
Seek Labs Named Emerging Finalist in Healthcare and Life Sciences Category for 2024 Utah Business Innovation Awards August 8, 2024 Seek Labs is excited to announce its selection as an Emerging finalist in the Healthcare and Life Sciences category for the 2024 Utah Business Innovation Awards. This honor recognizes Seek Labs’ groundbreaking diagnostics innovation, SeekIt™,…
Doug Gladue, VP of Veterinary Pharmaceutical Development, Presents at PROCINORTE Priority Animal Diseases 2024 Workshop June 12, 2024 Today, Dr. Douglas Gladue, VP of Veterinary Pharmaceutical Development, presented at the PROCINORTE 2024 Priority Animal Diseases Virtual Workshop. Dr. Gladue spoke about Seek Labs’ development of CRISPR-based pharmaceuticals for human and animal diseases. Addressing a virtual assembly…
Stay connected
Stay connected to company milestones, scientific insights, and the work unfolding across BioSeeker, SAT, and Seek Diagnostics.